)
Branded, patented pharma companies that have not agreed to lower drug prices via MFN agreements will face 100 per cent tariffs
US tariffs on patented drugs may have limited immediate impact on India, but industry flags uncertainty as policy ties relief to pricing and manufacturing shifts
Updated On : 04 Apr 2026 | 12:04 AM ISTA year after it was announced, 'Liberation Day' has altered the mechanics of global trade as tariffs have succeeded in forcing negotiations in some cases and reshaping supply chains in others
Updated On : 02 Apr 2026 | 2:11 PM ISTThe Nifty Metal index fell over 3 per cent to hit an intraday low of 11,052.55, dragged by Hindustan Copper, Hindustan Zinc, APL Apollo Tubes, Tata Steel, SAIL, Adani Enterprises, and Jindal Steel
Updated On : 02 Apr 2026 | 12:51 PM ISTPharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts suggest shifting to domestic-focused companies. Here's the investment strategy.
The US plans tariffs of up to 100 per cent on imported medicines to reduce foreign dependence and boost domestic manufacturing, a move that could reshape global pharmaceutical supply chains
The US has announced a 100 per cent tariff on patented pharma imports from countries like India without reshoring deals, aiming to boost local production, while generics have been exempted for now
Duties for products made by certain larger companies will take effect in 120 days, while items from smaller manufacturers won't be hit for another 180 days, according to a White House statement
US plans 50% tariffs on many derivative goods, based on import value while others will face 25% duties, with some products taxed at even lower rates
Talks on the e-commerce import duty ban reached a deadlock between Brazil and the US
The conclusion of negotiations for the agreement was announced by Australian PM Anthony Albanese and Ursula von der Leyen, the EU's top executive
The unusually rapid pace of these 76 inquiries raises concerns over due process, with expectations that responses may align closely with the Trump administration's preferred outcomes
The production-linked incentive scheme for large-scale electronics manufacturing, due to end on March 31, has propelled India as the second-largest smartphone maker in the world. What's its future?
India will sign the trade pact with the US after Washington completes work on a new tariff architecture, Commerce Secretary Rajesh Agrawal said, adding there is no stand-off in the ongoing talks
Today's Opinion page covers Trump's tariff strategy, the Supreme Court's passive euthanasia ruling, rupee depreciation amid West Asia tensions, farm diversification and a Syria war book review
After the courts blocked earlier tariffs, the Trump administration turns to Section 301 probes to justify new duties-putting India and other major trading partners under scrutiny
New Delhi expected to sign an interim pact in March, but fresh US investigations and uncertainty over tariffs have slowed negotiations, government sources say
President Donald Trump is scrambling to replace the revenue the federal government lost when the Supreme Court struck down his biggest and boldest tariffs last month. If the effort succeeds, congressional Democrats warn in a study out Friday, the administration's import taxes will cost American households an average of $2,512 in 2026, up 44% from $1,745 in tariff costs last year. And this at a time when U.S. consumers are already angry over the high cost of living and the war with Iran is pushing up energy prices. "Despite a Supreme Court ruling that much of Trump's tariff agenda is illegal, the Trump administration refuses to provide relief for families," said Sen. Maggie Hassan of New Hampshire, the top Democrat on the Joint Economic Committee. "As American families continue to struggle with high costs, the President keeps choosing to institute new tariffs that will push prices even higher." Calling the study "phony," White House spokesman Kush Desai said "President Trump will ...
The US Trade Representative has launched an unfair trade practices probe into 60 countries, including India, alleging failure to block imports of goods produced using forced labour
USTR opens Section 301 investigations into 16 economies, including India, over excess manufacturing capacity that Washington says undermines US industrial revival